Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06334276
Recruiting Observational

Developing an Utstein-style Danish Drowning Registry: Nationwide Fatal and Nonfatal Drowning Data Since 2016

NCT06334276 · tracked via the Priya Life Science Denmark tracker
Sponsor
Prehospital Center, Region Zealand
Phase
Observational
Started
2016-01-01
Last updated
2024-11-29

Condition(s) studied

DrowningDrowning, NearDrowning; AsphyxiaDrowning and Nonfatal SubmersionDrowning or Immersion of Unknown IntentDrowning and Submersion, Undetermined IntentDrowning and Submersion While in Bath-TubDrowning and Submersion While in Natural WaterDrowning and Submersion While in Swimming-Pool

Investigational drug(s) / intervention(s)

Drowning

Drowning: Drowning is defined by the WHO in 2002 as "the process of experiencing respiratory impairment from submersion or immersion in liquid"

Study summary

This nationwide, registry-based study aims to link Danish Prehospital Drowning Data data with inhospital data to develop a Utstein-style Danish Drowning Registry. This study will report mortality and neurological outcomes 30 days after a drowning incident since 2016.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Drowning * Being registered in the Danish Prehospital Drowning Data with a valid civil registration number to allow for linkage with the inhospital electronic medical records Exclusion Criteria: * Obvious signs of irreversible death (decapitation, decomposition, post-mortem lividity, post-mortem rigidity). * Declared dead on scene. * A valid Do-Not-Attempt-Resuscitation order or other code status orders limiting life-sustaining therapies. * An invalid civil registration number.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Prehospital Center Region Zealand Næstved Region Sjælland Recruiting

More Prehospital Center, Region Zealand trials in Denmark

The Emergency Call on Drowning Recruiting
Using Machine Learning to Optimise the Danish Drowning Formula Active, not recruiting
Primary or Secondary Drowning Active, not recruiting

Other trials for the same condition

The Emergency Call on Drowning Recruiting
Using Machine Learning to Optimise the Danish Drowning Formula Active, not recruiting
Primary or Secondary Drowning Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06334276 on ClinicalTrials.gov ↗ ← All trials in Denmark